Vaxcyte Confident Of Pneumococcal Vaccine Dominance After Phase I/II Results

Phase III Adult Trials To Begin In 2025

 
• By Mandy Jackson
  
Pneumococcal vaccine in a vial, immunization and treatment of infection, vaccine used for disease prevention
Vaxcyte will initiate adult and infant trials for VAX-31 in 2025 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D